image description


The District Policy Group learned of a federal agency plan to have Medicare Advantage Plans limit contracts to pre-approved manufacturers of specific durable medical equipment (DME) technologies. Representing our client—a global medical device manufacturer—we engaged the federal agency on the immense economic consequences of such a proposal, working with the client to provide data and compelling arguments against such a proposal. We encouraged the large trade association representing medical device companies to address the proposal, providing information for them to include in federal comments, and helped provider and patient advocacy organizations to comment on the clinical and patient care implications of the proposal. As a result, the agency issued a final regulation that protected specific types of technologies from inclusion in the contract limiting process, eliminating risk for our client and other companies that serve similar markets.